| AHF | dosage | Antihemophilic Factor; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Advate | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Antihemophilic Factor; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Alphanate | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Antihemophilic Factor; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Antihemophilic Factor | Powder for solution; Solution (IV injection) | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Benefix (Genetics Institute) | dosage | Christmas factor; Coagulation factor IX precursor; PTC; Plasma thromboplastin component; Factor IX |
| Bioclate | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Antihemophilic Factor; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Christmas factor | dosage | Factor IX; Coagulation factor IX precursor; PTC; Plasma thromboplastin component; Benefix (Genetics Institute) |
| Coagulation factor IX precursor | dosage | Christmas factor; Factor IX; PTC; Plasma thromboplastin component; Benefix (Genetics Institute) |
| Coagulation factor VII precursor | dosage | Coagulation factor VIIa; Eptacog alfa; Proconvertin; SPCA; Serum prothrombin conversion accelerator; NovoSeven (Novo Nordisk) |
| Coagulation factor VIII precursor | dosage | AHF; Antihemophilic Factor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Coagulation factor VIIa | Solution (IV injection); Solution (IV infusion); Tablet; Powder for solution | Coagulation factor VII precursor; Eptacog alfa; Proconvertin; SPCA; Serum prothrombin conversion accelerator; NovoSeven (Novo Nordisk) |
| Eptacog alfa | dosage | Coagulation factor VII precursor; Coagulation factor VIIa; Proconvertin; SPCA; Serum prothrombin conversion accelerator; NovoSeven (Novo Nordisk) |
| Factor IX | Liquid; Powder for Solution | Christmas factor; Coagulation factor IX precursor; PTC; Plasma thromboplastin component; Benefix (Genetics Institute) |
| Helixate | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Antihemophilic Factor; Antihemophilic Factor FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Helixate FS | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Antihemophilic Factor; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Hemofil M | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Antihemophilic Factor; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Humate-P | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Antihemophilic Factor; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Hyate:C | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Antihemophilic Factor; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Interferon alpha-2 precursor | dosage | Ribavirin and Alfa Interferon (Intron A); Interferon alpha-A; LeIF A; Rebetron (Schering-Plough) |
| Interferon alpha-A | dosage | Interferon alpha-2 precursor; Ribavirin and Alfa Interferon (Intron A); LeIF A; Rebetron (Schering-Plough) |
| Koate-HP | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Antihemophilic Factor; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Kogenate | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Antihemophilic Factor; Antihemophilic Factor FS; Monarc-M; Monoclate-P; Nateglinide |
| Kogenate FS | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Antihemophilic Factor; Monarc-M; Monoclate-P; Nateglinide |
| LeIF A | dosage | Interferon alpha-2 precursor; Interferon alpha-A; Ribavirin and Alfa Interferon (Intron A); Rebetron (Schering-Plough) |
| Monarc-M | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Antihemophilic Factor; Monoclate-P; Nateglinide |
| Monoclate-P | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Antihemophilic Factor; Nateglinide |
| Nateglinide | dosage | AHF; Coagulation factor VIII precursor; Procoagulant component; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Antihemophilic Factor |
| NovoSeven (Novo Nordisk) | dosage | Coagulation factor VII precursor; Eptacog alfa; Proconvertin; SPCA; Serum prothrombin conversion accelerator; Coagulation factor VIIa |
| PTC | dosage | Christmas factor; Coagulation factor IX precursor; Factor IX; Plasma thromboplastin component; Benefix (Genetics Institute) |
| Plasma thromboplastin component | dosage | Christmas factor; Coagulation factor IX precursor; PTC; Factor IX; Benefix (Genetics Institute) |
| Procoagulant component | dosage | AHF; Coagulation factor VIII precursor; Antihemophilic Factor; Advate; Alphanate; Bioclate; Helixate; Helixate FS; Hemofil M; Humate-P; Hyate:C; Koate-HP; Kogenate; Kogenate FS; Monarc-M; Monoclate-P; Nateglinide |
| Proconvertin | dosage | Coagulation factor VII precursor; Eptacog alfa; Coagulation factor VIIa; SPCA; Serum prothrombin conversion accelerator; NovoSeven (Novo Nordisk) |
| Rebetron (Schering-Plough) | dosage | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Ribavirin and Alfa Interferon (Intron A) |
| Ribavirin and Alfa Interferon (Intron A) | Capsule; Powder for solution; Solution (injection) | Interferon alpha-2 precursor; Interferon alpha-A; LeIF A; Rebetron (Schering-Plough) |
| SPCA | dosage | Coagulation factor VII precursor; Eptacog alfa; Proconvertin; Coagulation factor VIIa; Serum prothrombin conversion accelerator; NovoSeven (Novo Nordisk) |
| Serum prothrombin conversion accelerator | dosage | Coagulation factor VII precursor; Eptacog alfa; Proconvertin; SPCA; Coagulation factor VIIa; NovoSeven (Novo Nordisk) |